Terms: = Cervical cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Clinical Outcome
2 results:
1. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in cervical cancer Brachytherapy: Results From the EMBRACE I Study.
Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
[TBL] [Abstract] [Full Text] [Related]
2. Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix.
Pillai MR; Jayaprakash PG; Nair MK
J Cancer Res Clin Oncol; 1998; 124(8):456-61. PubMed ID: 9750023
[TBL] [Abstract] [Full Text] [Related]
